ArticleJournal of cellular and molecular medicine2026
The Role of HER2 and RANK in Breast Cancer and New Therapeutic Approaches With Denosumab, Anti-HER2 Antibodies and Immunotherapy.
Panagiotis Sarantis et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.